Historique
Rapport
JAR wars: the question of schools-based drug testing
Auteur(s) :
HALLAM, C.
Année
2010
Page(s) :
15 p.
Sous-type de document :
Revue de la littérature / Literature review
Langue(s) :
Anglais
Éditeur(s) :
London : International Drug Policy Consortium (IDPC)
Collection :
Briefing Paper
Refs biblio. :
47
Domaine :
Drogues illicites / Illicit drugs
Thésaurus mots-clés
DEPISTAGE
;
URINE
;
MILIEU SCOLAIRE
;
ADOLESCENT
;
EVALUATION
;
SALIVE
;
METHODE
;
ETHIQUE
;
PREVENTION
Thésaurus géographique
ETATS-UNIS
;
ROYAUME-UNI
;
PHILIPPINES
Résumé :
Schools-based drug testing is a tool used in the drug use prevention strategies of a number of countries; so far, the United States has made the most extensive use of it, and, while some other countries have adopted the intervention, the vast majority of the research stems from the US. The evidence base, however, remains an exceedingly narrow one. Moreover, the research thus far has not demonstrated that schools-based drug testing is significantly effective at preventing or reducing drug use. When we examine the ethical dimension, it is apparent that there are very significant risks associated with its deployment, centring on the potential for damage and disruption in the relationship between the educational institution staff, family and the student. The imposition of this type of surveillance reduces the trust that is at the heart of both the educational and socialising role of the school. On balance, therefore, weighing up the potential benefits in terms of prevention with the financial costs, implementation problems and the risks to a fundamental relation for society and its youthful members, IDPC believes that schools-based drug testing is not an option that policy-makers would be wise to adopt. Resources are better directed toward enhancing the sense of engagement and connection between school and student, and in addressing factors in the social, political and economic environment that drive people toward harmful and problematic forms of drug use in the first place. [Extract of the document]
Affiliation :
International Drug Policy Consortium, London, UK